Public annual accounts

MALAGILULE financials

A multi-period view of the public annual-account figures reported for MALAGILULE, with comparable measures and links to available source documents.

Company overview
Registry number

0842652262

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

2025 versus 2024

Operating line
€132,949
EBITDA
€40,321

-15.4%

Total assets
€76,665

+60.2%

Equity
€32,518

+38.2%

EBITDA margin +30.3% · Equity ratio +42.4%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO
Fiscal year
Operating line
EBITDA
Total assets
Equity
Filing
202531 Dec 2025€132,949€40,321€76,665€32,518-
202431 Dec 2024€0€47,683€47,869€23,522-
Operating line combines reported turnover and gross-margin rows by fiscal year. Gross-margin rows are not reported turnover and are not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report